Early Ultrasound Evaluation Identifies Excellent Responders to Neoadjuvant Systemic Therapy in Patients with Triple Negative Breast Cancer

BACKGROUND: Heterogeneity exists in triple negative breast cancer (TNBC) response to standard anthracycline/taxane based neoadjuvant systemic therapy (NAST) with 40–50% of patients having pathologic complete response to therapy (pCR). Early assessment of imaging response during NAST may identify a s...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Cancer
Autori principali: Adrada, Beatriz E., Candelaria, Rosalind, Moulder, Stacy, Thompson, Alastair, Wei, Peng, Whitman, Gary J., Valero, Vicente, Litton, Jennifer K., Santiago, Lumarie, Scoggins, Marion E., Moseley, Tanya, White, Jason B, Ravenberg, Elizabeth. E, Yang, Wei T., Rauch, Gaiane M.
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2021
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC8319084/
https://ncbi.nlm.nih.gov/pubmed/33878210
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.33604
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi